National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting, 5441-5442 [2014-01919]
Download as PDF
<![CDATA[
5441
Federal Register / Vol. 79, No. 21 / Friday, January 31, 2014 / Notices
is authorized by an amendment to
Section 487E (42 U.S.C. 288–5); the
Contraception and Infertility Research
LRP (CIR–LRP) is authorized by Section
487B (42 U.S.C. 288–2); and the Health
Disparities Research Loan Repayment
Program (HD–LRP) is authorized by
Section 485G (42 U.S.C. 287c–33).
The Loan Repayment Programs can
repay up to $35,000 per year toward a
participant’s extant eligible educational
loans, directly to financial institutions.
The information proposed for collection
will be used by the Division of Loan
Repayment to determine an applicant’s
eligibility for participation in the
program.
Frequency of Response: Initial
application and one or two-year renewal
application.
Affected Public: Individuals or
households; Nonprofits; and Businesses
or other for-profit.
Type of Respondents: Physicians,
other scientific or medical personnel,
and institutional representatives.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
34,925.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of respondents
Type of respondent
Estimated
number of responses per
respondent
Average burden hours per
response
Annual burden hours requested
20
20
60
1
1
1
10
1
30/60
200
20
30
Intramural LRPs
Initial Applicants ........................................................................
Advisors/Supervisors ................................................................
Recommenders ........................................................................
Subtotal .............................................................................
Extramural LRPs
Initial Applicants ........................................................................
Advisors/Supervisors ................................................................
100
........................
........................
250
1,800
1,600
1
1
11
1
19,800
1,600
Recommenders ........................................................................
5,400
1
30/60
2,700
Subtotal .............................................................................
8,800
........................
........................
24,100
Intramural LRPs
Renewal Applicants ..................................................................
Advisors/Supervisors ................................................................
40
40
1
1
7
2
280
80
Subtotal .............................................................................
Extramural LRPS
Renewal Applicants ..................................................................
Advisors/Supervisors ................................................................
Recommenders ........................................................................
80
........................
........................
360
930
690
2,790
1
1
1
8
2
30/60
7,440
1,380
1,395
Subtotal .............................................................................
4,410
........................
........................
10,215
Dated: January 27, 2014.
Adrienne Boice,
Project Clearance Liaison, Division of Loan
Repayment, NIH.
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
[FR Doc. 2014–02018 Filed 1–30–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
tkelley on DSK3SPTVN1PROD with NOTICES
National Institutes of Health
National Institute of Dental &
Craniofacial Research; Notice of
Closed Meeting Pursuant to Section
10(d) of the Federal Advisory
Committee Act, as Amended (5 U.S.C.
App.), Notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
VerDate Mar<15>2010
22:14 Jan 30, 2014
Jkt 232001
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel; RFA: DE–14–003
Date: February 28, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, #602,
6701 Rockledge Drive, Bethesda, MD 20892.
Contact Person: Jayalakshmi Raman, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Institute of Dental and
Craniofacial Research, One Democracy Plaza,
Room 670, Bethesda, MD 20892–4878, 301–
594–2904, ramanj@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.121, Oral Diseases and
Disorders Research, National Institutes of
Health, HHS)
PO 00000
Frm 00074
Fmt 4703
Sfmt 4703
Dated: January 27, 2014.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–01916 Filed 1–30–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
E:\FR\FM\31JAN1.SGM
31JAN1
5442
Federal Register / Vol. 79, No. 21 / Friday, January 31, 2014 / Notices
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National
Institute of Diabetes and Digestive and
Kidney Diseases Special Emphasis
Panel, NIDDK MAPP (M3 and M4)
Application Telephone Review.
Date: February 26, 2014.
Time: 2:00 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Two Democracy Plaza, 6707 Democracy
Boulevard,Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Xiaodu Guo, MD,
Ph.D., Scientific Review Officer, Review
Branch, DEA, NIDDK, National
Institutes Of Health, Room 761, 6707
Democracy Boulevard, Bethesda, MD
20892–5452, (301) 594–4719, guox@
extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: January 27, 2014
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–01919 Filed 1–30–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
tkelley on DSK3SPTVN1PROD with NOTICES
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
VerDate Mar<15>2010
22:14 Jan 30, 2014
Jkt 232001
Special Emphasis Panel, NIDDK MAPP (M3
and M4) Application Telephone Review.
Date: February 26, 2014.
Time: 5:30 p.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Xiaodu Guo, MD, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes Of Health,
Room 761, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–4719,
guox@extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, Metagenomic
Studies of the Gut Microbiomes of Obese and
Lean Twins.
Date: March 7, 2014.
Time: 12:00 p.m. To 2:00 p.m.
Agenda: To Review And Evaluate Grant
Applications.
Place: National Institutes Of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, Md 20892, (Telephone
Conference Call).
Contact Person: Thomas A. Tatham, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes Of Health,
Room 760, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–3993,
tathamt@mail.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, NASH CRN
Applications.
Date: March 11, 2014.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Jian Yang, Ph.D., Scientific
Review Officer, Review Branch, DEA,
NIDDK, National Institutes Of Health, Room
755, 6707 Democracy Boulevard, Bethesda,
MD 20892–5452, (301) 594–7799, yangj@
extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, Systems Biology.
Date: March 20, 2014.
Time: 11:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Thomas A. Tatham, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes Of Health,
Room 760, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–3993,
tathamt@mail.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, Intestinal Stem Cells
U01s.
Date: April 17, 2014.
PO 00000
Frm 00075
Fmt 4703
Sfmt 4703
Time: 8:00 a.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Maria E. Davila-Bloom,
Ph.D., Scientific Review Officer, Review
Branch, DEA, NIDDK, National Institutes Of
Health, Room 758, 6707 Democracy
Boulevard, Bethesda, MD 20892–5452, (301)
594–7637, davila-bloomm@
extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: January 27, 2014.
David Clary,
Program Analyst Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–01920 Filed 1–30–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Initial Review Group; Kidney, Urologic and
Hematologic Diseases D Subcommittee.
Date: March 5–6, 2014.
Open: March 5, 2014, 8:00 a.m. to 8:30 a.m.
Agenda: To review policy and procedures.
Place: Embassy Suites Hotel, 300 Military
Road, Washington, DC 20015.
E:\FR\FM\31JAN1.SGM
31JAN1
]]>Agencies
[Federal Register Volume 79, Number 21 (Friday, January 31, 2014)]
[Notices]
[Pages 5441-5442]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-01919]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose
[[Page 5442]]
confidential trade secrets or commercial property such as patentable
material, and personal information concerning individuals associated
with the grant applications, the disclosure of which would constitute a
clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Diabetes and Digestive and
Kidney Diseases Special Emphasis Panel, NIDDK MAPP (M3 and M4)
Application Telephone Review.
Date: February 26, 2014.
Time: 2:00 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard,Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Xiaodu Guo, MD, Ph.D., Scientific Review Officer,
Review Branch, DEA, NIDDK, National Institutes Of Health, Room 761,
6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301) 594-4719,
guox@extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
Dated: January 27, 2014
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-01919 Filed 1-30-14; 8:45 am]
BILLING CODE 4140-01-P
